Optimising the Use of β-Adrenoceptor Antagonists in Coronary Artery Disease

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.6, 2005-01, pp. : 787-797

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of β-Adrenoceptor Antagonists in Older Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Co-Morbidity: Safety Issues

By Andrus Miranda R. Loyed Joyce V.

Drugs & Aging, Vol. 25, Iss. 2, 2008-01 ,pp. : 131-144

Adis International

Access to resources Recommend Favorite

Pediatric Heart Failure Therapy with β-Adrenoceptor Antagonists

By Foerster Susan R. Canter Charles E.

Pediatric Drugs, Vol. 10, Iss. 2, 2008-01 ,pp. : 125-134

Adis International

Access to resources Recommend Favorite

Metabolic Effects of β-Adrenoceptor Antagonists with Special Emphasis on Carvedilol

By Kveiborg Britt Christiansen Buris Major-Petersen Atheline Torp-Pedersen Christian

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 4, 2006-01 ,pp. : 209-217

Adis International

Access to resources Recommend Favorite

Recent Advances in Identification and Characterization of &bgr;-Adrenoceptor Agonists and Antagonists

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 2, 2007-01 ,pp. : 207-216

Bentham Science Publishers

Access to resources Recommend Favorite

The use of α-adrenoceptor antagonists in lower urinary tract disease

By Chess-Williams Russell

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 2, 2002-02 ,pp. : 167-172

Informa Healthcare

Access to resources Recommend Favorite